|
Eisen et al. 2005
|
Population-based, cross-sectional, prevalence, medical evaluation
|
1,061 deployed vs 1,128 nondeployed
|
Persistent and clinically significant bone or joint symptoms with or without joint effusion, and treatment with anti-inflammatory agents, narcotic pain medications, ornonnarcotic pain medications
|
Prevalence: 6.4% vs. 6.8%, OR 1.15 (95% CI 0.70-1.89)
|
Age, sex, race, yearsof education, cigarette-smoking, duty type, service branch, rank
|
Low participation rates, especially among nondeployed
|
